Crucell
| Use attributes for filter ! | |
| Headquarters | Leiden |
|---|---|
| Netherlands | |
| Owners | Johnson & Johnson |
| Founded | 2000 |
| Type of business | Subsidiary |
| Privately held company | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2609962 |
About Crucell
Crucell is a biotechnology company specializing in vaccines and biopharmaceutical technologies. In September 2009 Johnson & Johnson bought 18% stake in Crucell for €302 million in order to collaborate on the development of a flu vaccine.
